← 返回

近红外可激活仿生纳米平台用于原位胶质母细胞瘤的肿瘤特异性药物释放、穿透及化疗-光热协同治疗

英文原题:Near Infrared-Activatable Biomimetic Nanoplatform for Tumor-Specific Drug Release, Penetration and Chemo-Photothermal Synergistic Therapy of Orthotopic Glioblastoma.

查看英文原题

Near Infrared-Activatable Biomimetic Nanoplatform for Tumor-Specific Drug Release, Penetration and Chemo-Photothermal Synergistic Therapy of Orthotopic Glioblastoma.

PubMed 2024/07/11(内容时间) Int J Nanomedicine Q1 · IF 8.7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

这种 NIR 激活的仿生伪装巨噬细胞膜基纳米颗粒通过巨噬细胞膜和特异性配体的修饰增强了药物递送的靶向能力。它同时实现了协同化疗-光热治疗,提高了治疗效果。与传统治疗方式相比,它提供了一种精确、高效且协同的方法,可能有助于胶质母细胞瘤治疗的进展。

研究思路结论见上方概要

多形性胶质母细胞瘤(GBM)是一种高度侵袭性且预后极具挑战性的脑癌,由于血脑屏障(BBB)的存在以及难以在深部GBM病灶中维持有效的药物蓄积,给当前的治疗带来了重大障碍。

我们提出了一种仿生纳米平台,其具有angiopep-2修饰的巨噬细胞膜,负载了由indocyanine green(ICG)模板化的SN38自组装体(AM-NP),通过特异性配体-受体相互作用,实现主动肿瘤靶向和有效穿透血脑屏障。

在肿瘤部位积累后,这些纳米颗粒实现了高药物浓度。随后,激光照射与化疗药物SN38释放的联合应用诱导了协同的化学-光热治疗。与缺乏细胞膜包裹的裸纳米颗粒(NPs)相比,AM-NPs显著抑制了肿瘤生长,明显提高了生存率,并表现出优异的生物相容性,副作用极小。

展开英文摘要原文

We present a biomimetic nanoplatform with angiopep-2-modified macrophage membrane, loaded with indocyanine green (ICG) templated self-assembly of SN38 (AM-NP), facilitating active tumor targeting and effective blood-brain barrier penetration through specific ligand-receptor interaction.

Upon accumulation at tumor sites, these nanoparticles achieved high drug concentrations. Subsequent combination of laser irradiation and release of chemotherapy agent SN38 induced a synergistic chemo-photothermal therapy. Compared to bare nanoparticles (NPs) lacking cell membrane encapsulation, AM-NPs significantly suppressed tumor growth, markedly enhanced survival rates, and exhibited excellent biocompatibility with minimal side effects.

This NIR-activatable biomimetic camouflaging macrophage membrane-based nanoparticles enhanced drug delivery targeting ability through modifications of macrophage membranes and specific ligands. It simultaneously achieved synergistic chemo-photothermal therapy, enhancing treatment effectiveness. Compared to traditional treatment modalities, it provided a precise, efficient, and synergistic method that might have contributed to advancements in glioblastoma therapy.

论文信息

作者
Li M、Zhang X、Zhou Y、Chu Y、Shen J、Cai Y、Sun X
单位
Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, 310014, People's Republic of China.China
期刊
International journal of nanomedicine2024
原文标识
PubMed 39011386 · DOI 10.2147/IJN.S466268